Details of the Drug

General Information of Drug (ID: DM22IOE)

• Drug Name: TT-034
• Synonyms: BLT-HCV; OBP-701; RNAi therapy (hepatitis C virus infection); TT-033; TT-033i; DdRNAi therapy (HCV), Benitec; RNAi therapy (HCV), Benitec; RNAi therapy (hepatitis C virus infection), Tacere/ Pfizer

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis C virus infection	1E51.1	Phase 1/2	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C11H16ClN5
  Canonical SMILES: CC(C)CN1C(=NN=N1)C2=CC(=CC=C2)N.Cl
  InChI: InChI=1S/C11H15N5.ClH/c1-8(2)7-16-11(13-14-15-16)9-4-3-5-10(12)6-9;/h3-6,8H,7,12H2,1-2H3;1H
  InChIKey: QRFDPUUTKDZZIX-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 3031869
  TTD ID: D0D5TN

References

• [1] ClinicalTrials.gov (NCT01899092) Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C. U.S. National Institutes of Health.